HOOD vs. CRSP

Last updated Jun 6, 2026

HOOD (Robinhood Markets, Inc.) and CRSP (CRISPR Therapeutics AG) are both stocks. HOOD operates in Capital Markets (Financial Services), while CRSP operates in Biotechnology (Healthcare). Over the past 3 years, HOOD returned 108.34%/yr vs -7.06%/yr for CRSP. At a 0.50 correlation, their price movements are largely independent.

Performance

HOOD vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Robinhood Markets, Inc. (HOOD) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, HOOD achieves a -27.08% return, which is significantly lower than CRSP's -1.14% return.

HOOD

• 1D: -6.63%
• 1M: 4.33%
• YTD: -27.08%
• 6M: -37.50%
• 1Y: 13.74%
• 3Y*: 108.34%
• 5Y*: —
• 10Y*: —

CRSP

• 1D: -8.97%
• 1M: -5.88%
• YTD: -1.14%
• 6M: -8.86%
• 1Y: 34.40%
• 3Y*: -7.06%
• 5Y*: -14.47%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HOOD vs. CRSP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
HOOD Robinhood Markets, Inc.	-27.08%	203.54%	192.46%	56.51%	-54.17%	-48.99%
CRSP CRISPR Therapeutics AG	-1.14%	33.23%	-37.12%	54.00%	-46.36%	-36.32%

Correlation

The correlation between HOOD and CRSP is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.42
Correlation (3Y) Calculated over the trailing 3-year period	0.43
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021	0.50

Fundamentals

Market Cap HOOD : $75.46B CRSP : $4.98B
EPS HOOD : $2.07 CRSP : -$6.24
PS Ratio HOOD : 19.32 CRSP : 1.15K
PB Ratio HOOD : 7.79 CRSP : 2.74
Total Revenue (TTM) HOOD : $3.91B CRSP : $4.10M
Gross Profit (TTM) HOOD : $2.86B CRSP : -$171.17M
EBITDA (TTM) HOOD : $1.80B CRSP : -$509.21M

Return for Risk

HOOD vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HOOD

HOOD Risk / Return Rank: 48
HOOD Sharpe Ratio Rank: 49
HOOD Sortino Ratio Rank: 50
HOOD Omega Ratio Rank: 48
HOOD Calmar Ratio Rank: 47
HOOD Martin Ratio Rank: 47

CRSP

CRSP Risk / Return Rank: 58
CRSP Sharpe Ratio Rank: 60
CRSP Sortino Ratio Rank: 59
CRSP Omega Ratio Rank: 56
CRSP Calmar Ratio Rank: 60
CRSP Martin Ratio Rank: 56

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HOOD vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Robinhood Markets, Inc. (HOOD) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HOOD	CRSP	Difference
Sharpe ratio: Return per unit of total volatility	0.20	0.55	-0.35
Sortino ratio: Return per unit of downside risk	0.80	1.22	-0.42
Omega ratio: Gain probability vs. loss probability	1.09	1.14	-0.05
Calmar ratio: Return relative to maximum drawdown	0.24	0.82	-0.58
Martin ratio: Return relative to average drawdown	0.44	1.38	-0.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HOOD vs. CRSP - Sharpe Ratio Comparison

The current HOOD Sharpe Ratio is 0.20, which is lower than the CRSP Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of HOOD and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HOOD	CRSP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.20	0.55	-0.35
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.24	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.26	0.23	+0.04

Drawdowns

HOOD vs. CRSP - Drawdown Comparison

The maximum HOOD drawdown since its inception was -90.21%, which is greater than CRSP's maximum drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for HOOD and CRSP.

Drawdown Indicators

	HOOD	CRSP	Difference
Max Drawdown Largest peak-to-trough decline	-90.21%	-85.11%	-5.10%
Max Drawdown (1Y) Largest decline over 1 year	-57.26%	-42.25%	-15.01%
Max Drawdown (3Y) Largest decline over 3 years	-57.26%	-64.91%	+7.65%
Max Drawdown (5Y) Largest decline over 5 years	—	-80.68%	—
Current Drawdown Current decline from peak	-45.91%	-75.32%	+29.41%
Average Drawdown Average peak-to-trough decline	-60.96%	-49.19%	-11.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.12%	25.06%	+6.06%

Volatility

HOOD vs. CRSP - Volatility Comparison

Robinhood Markets, Inc. (HOOD) has a higher volatility of 23.12% compared to CRISPR Therapeutics AG (CRSP) at 19.12%. This indicates that HOOD's price experiences larger fluctuations and is considered to be riskier than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HOOD	CRSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.12%	19.12%	+4.00%
Volatility (6M) Calculated over the trailing 6-month period	50.46%	43.66%	+6.80%
Volatility (1Y) Calculated over the trailing 1-year period	69.04%	62.97%	+6.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	74.06%	60.69%	+13.37%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	74.06%	64.38%	+9.68%

Dividends

HOOD vs. CRSP - Dividend Comparison

Neither HOOD nor CRSP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both HOOD and CRSP in my portfolio?

HOOD and CRSP have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, HOOD or CRSP?

HOOD has higher volatility (23.12%) compared to CRSP (19.12%). In terms of maximum drawdown, HOOD dropped -90.21% vs CRSP's -85.11%.

Which has better risk-adjusted returns?

CRSP currently has the higher Sharpe Ratio (0.55 vs 0.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.